Evaluation of the efficacy of intervention in the management of AD chronic disease based on the theory of “prevention of the recrudescence of disease”
Abstract
Background:
Atopic dermatitis (AD) is a common inflammatory skin disease with a chronic course and a high recurrence.
Objective:
Based on the theory of “prevention and recovery after ulceration”, the application value and significance of compound ginseng cicada decoction in the intervention of chronic disease management in patients with AD were retrospectively analyzed.
Methods:
Through clinical retrospective observation, 60 patients with spleen deficiency and moisture type AD admitted to the outpatient clinic of our hospital after January 2019 were analyzed. After comprehensive treatment until the patient’s Investigator’s Global Assessment (IGA) Scale score is lower than 2 points, the study group was divided into a research group and a control group, according to the actual clinical follow-up whether to take compound ginseng cicada soup. The control group carried out chronic disease management education, conventional emollient topical with no drug maintenance intervention, and the research group included clinical patients who were orally administered to compound ginseng cicada decoction for 1 month, observed for 3 months, and compared with the clinical recurrence (recurrence rate, time to first recurrence, severity at recurrence, degree of pruritus), and the quality of life.
Results:
After 3 months, the relapse rate, recurrence severity, itching degree and quality of life impact scores of the study group were significantly lower than those of the control group, and there were no obvious adverse events.
Conclusion:
The combined application of compound ginseng cicada decoction in the management of chronic diseases in patients with atopic dermatitis has the positive significance of reducing AD recurrence, alleviating the severity of recurrence, and effectively improving the life quality of patients. This method has high safety and is worthy of wide application.
References
[1]
Zhang J, Gao X. Dermatology and Venereology. Beijing: People’s Medical Publishing House. 2015; 165-168.
[2]
Bajgai J, Fadriquela A, Ara J, Begum R, Ahmed MF, Kim CS, Kim SK, Shim KY, Lee KJ. Balneotherapeutic effects of high mineral spring water on the atopic dermatitis-like inflammation in hairless mice via immunomodulation and redox balance. BMC Complementary and Alternative Medicine. 2017; 17(1): 1-9.
[3]
Li Q. Standardized treatment and long-term management of atopic dermatitis in children. Chinese Journal of Practical Pediatrics. 2021; 36(9): 645-648.
[4]
Chen Y, Chen X, Li Z, et al. The ideological connotation of preventing disease and its role in the prevention and treatment of skin diseases. Modern Distance Education of Chinese Medicine. 2022; 20(1): 3.
[5]
Zhang J, Ding X, Bian C, et al. Analysis on the origin and development of “preventive treatment of diseases” in traditional Chinese medicine. Chinese Medicine Information. 2017; 34(2): 44-45.
[6]
He X, Chen Y, Wang Y, et al. The effect of offline and online hybrid chronic disease management on the outcome of patients with systemic lupus erythematosus. Chongqing Medicine. 2022; 51(9): 5.
[7]
Shen H, Van Der Kleij RM, Van Der Boog PJ, Wang W, Song X, Li Z, Lou X, Chavannes N. Patients’ and healthcare professionals’ beliefs, perceptions and needs towards chronic kidney disease self-management in China: A qualitative study. BMJ Open. 2021; 11(3): e044059.
[8]
Helvaci A, Gok Metin Z. The effects of nurse-driven self-management programs on chronic obstructive pulmonary disease: A systematic review and meta-analysis. Journal of Advanced Nursing. 2020; 76(11): 2849-2871.
[9]
Sun K, Han X, Sun X, et al. Research progress in the prevention and treatment of atopic dermatitis with traditional Chinese medicine. Chinese Journal of Experimental Formulas. 2022(028-005).
[10]
Immunology Group of Dermatology Branch of Chinese Medical Association, Atopic Dermatitis Collaborative Research Center. Guidelines for Diagnosis and Treatment of Atopic Dermatitis in China (2014 Edition). Chinese Journal of Dermatology. 2014; 47(7): 511-514.
[11]
Chen D. Expert Consensus on TCM Diagnosis and Treatment of Atopic Dermatitis. Chinese Journal of Integrated Traditional Chinese and Western Medicine Dermatology. 2013; 12(1): 60-61.
[12]
Liu L, Pi X, Li W. The pathogenesis of atopic dermatitis and its regulation by traditional Chinese medicine. Shi Zhen Guo Yi Guo Yao. 2022(033-006).
[13]
Song Z, Wang H. Progress in the treatment of atopic dermatitis: New drugs, new methods, and new models. Chinese Journal of Dermatology. 2021; 54(2): 161-164.
[14]
Skjerven HO, Lie A, Vettukattil R, Rehbinder EM, LeBlanc M, Asarnoj A, Carlsen KH, Despriee ÅW, Färdig M, Gerdin SW, Granum B. Early food intervention and skin emollients to prevent food allergy in young children (PreventADALL): A factorial, multicentre, cluster-randomised trial. The Lancet. 2022; 399(10344): 2398-2411.
[15]
Xi M. Clinical research on treating atopic dermatitis based on the thinking of moistening skin and relieving itching in traditional Chinese medicine. New Chinese Medicine. 2021; 53(9): 4.
[16]
Zhao R, Qi Y, Fan L, et al. Two cases of severe prurigo-type atopic dermatitis treated with dupilumab. Chinese Journal of Dermatology. 2022; 55(4): 3.
[17]
Li Y, Li M. Expert consensus on the treatment of atopic dermatitis with systemic Janus kinase inhibitors. Journal of Practical Dermatology. 2022; 15(3): 7.
[18]
Li W, Zhang T, Qian H, et al. Clinical analysis of 0.1% mometasone furoate in the maintenance treatment of children with atopic dermatitis. Jilin Medicine. 2021; 42(7): 1574-1576.
[19]
Tan Q, Wang Y, Wang Y. Evaluation of the clinical application of Licorice Zinc Granules in reducing the recurrence of atopic dermatitis in children. Chinese Journal of Integrated Traditional Chinese and Western Medicine Dermatology. 2021; 20(5): 494-497.
Recommendations
Early Intervention and Health Promotion in the Management of Chronic Liver Disease
Liver disease is prevalent and a major public health concern. It has predominantly spread in the UK and worldwide, causing liver-related morbidity and mortality rates for the under 65s since 1970. This article aims to highlight the role of early ...
Experiences in mHealth for chronic disease management in 4 countries
ISABEL '11: Proceedings of the 4th International Symposium on Applied Sciences in Biomedical and Communication TechnologiesThis paper describes mHealth applications to deal with Non Communicable Diseases in North and Latin America: In Chile, a project focused on Diabetes Mellitus type 2; In the United States, Honduras, and Mexico, projects focused in diabetes, heart failure,...
Ambulatory care delivery for chronic disease management
BioMED '08: Proceedings of the Sixth IASTED International Conference on Biomedical EngineeringWe describe ambulatory care tools we have developed for application to elderly chronic disease patients, living at home and accessing local primary health care services. This project is an example of where improved expert support for decision making is ...
Comments
Please enable JavaScript to view thecomments powered by Disqus.Information & Contributors
Information
Published In
© 2024 – The authors. Published by IOS Press.
This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Publisher
IOS Press
Netherlands
Publication History
Published: 01 January 2024
Author Tags
Qualifiers
- Research-article
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 0Total Downloads
- Downloads (Last 12 months)0
- Downloads (Last 6 weeks)0
Reflects downloads up to 05 Mar 2025